Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
4.210
-0.200 (-4.54%)
Jul 17, 2026, 4:00 PM EDT - Market closed
Tevogen Bio Holdings Market Cap
Tevogen Bio Holdings has a market cap or net worth of $17.76 million as of July 17, 2026. Its market cap has decreased by -92.54% in one year.
Market Cap
17.76M
Enterprise Value
26.54M
1-Year Change
-92.54%
Ranking
Category
Stock Price
$4.21
ChartMarket Cap Chart
Since January 5, 2022, Tevogen Bio Holdings's market cap has decreased from $446.69M to $17.76M, a decrease of -96.02%. That is a compound annual growth rate of -50.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 17.76M | -73.00% |
| Dec 31, 2025 | 65.79M | -63.51% |
| Dec 31, 2024 | 180.30M | 2.42% |
| Dec 29, 2023 | 176.04M | -64.45% |
| Dec 30, 2022 | 495.15M | 10.85% |
| Jan 5, 2022 | 446.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuphoria Therapeutics | 19.35M |
| Longeveron | 19.27M |
| Lipocine | 18.80M |
| Allarity Therapeutics | 18.75M |
| Akari Therapeutics, | 18.73M |
| Werewolf Therapeutics | 17.90M |
| Quince Therapeutics | 17.90M |
| Jasper Therapeutics | 17.90M |